Travere Therapeutics Inc. (TVTX)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

17.32

0.09%

After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08
Revenue	145.24M	212.02M	227.49M	198.32M	175.34M	164.25M	154.94M	133.59M	99.89M	28.20M	-	-	-	-	-	-
Cost of Revenue	11.45M	7.59M	6.78M	6.13M	5.23M	5.53M	3.60M	4.55M	2.19M	570.98K	-	-	-	-	-	-
Gross Profit	133.79M	204.43M	220.71M	192.19M	170.10M	158.72M	151.33M	129.04M	97.71M	27.63M	-	-	-	-	-	-
Operating Income	-376.74M	-251.56M	-139.50M	-75.38M	-99.81M	-80.04M	-53.79M	-58.21M	-50.75M	-79.81M	-23.97M	-30.24M	-12.82K	-	-	-18.27K
Interest Income	21.77M	6.28M	1.99M	5.00M	10.05M	5.50M	700.00K	3.98M	7.75M	7.43M	-	21.83K	-	-	-	-
Pretax Income	-376.11M	-278.17M	-179.68M	-188.79M	-146.45M	-101.87M	-58.36M	-57.58M	105.47M	-113.40M	-33.75M	-30.34M	-14.82K	-	-	-18.27K
Net Income	-111.40M	-278.48M	-180.09M	-169.43M	-146.43M	-102.68M	-59.73M	-47.90M	117.24M	-110.94M	-33.82M	-30.34M	-14.82K	-	-	-18.27K
Selling & General & Admin	265.54M	220.21M	149.88M	135.80M	128.95M	103.65M	103.96M	98.02M	79.54M	59.64M	16.89M	30.26M	12.82K	-	-	13.43K
Research & Development	244.99M	235.78M	210.33M	131.77M	140.96M	123.76M	78.17M	70.85M	50.43M	47.80M	7.08M	662.50K	-	-	-	-
Other Expenses	11.39M	974.00K	231.00K	1.42M	-314.00K	-474.00K	1.11M	-264.00K	-296.00K	570.98M	-	28.96B	-	-	-	-
Operating Expenses	521.93M	455.99M	360.21M	267.57M	269.91M	227.41M	182.13M	168.87M	129.97M	107.44M	23.97M	30.26M	12.82K	-	-	13.43K
Interest Expense	11.33M	11.28M	20.14M	19.05M	18.83M	9.81M	1.19M	34.48M	-	-	19.50M	105.92K	2.00K	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	521.98M	463.58M	367.00M	273.70M	275.15M	232.94M	185.73M	173.42M	132.15M	108.01M	23.97M	30.26M	12.82K	-	-	18.27K
Income Tax	223.00K	313.00K	409.00K	-19.36M	-21.00K	811.00K	1.37M	-9.68M	-11.77M	-2.46M	75.78K	2.75K	-	-	-	-
Shares Outstanding (Basic)	74.27M	63.76M	59.83M	47.54M	42.34M	40.42M	38.77M	37.00M	33.56M	25.04M	14.19M	3.66M	106.68K	-	-	95.91M
Shares Outstanding (Diluted)	74.27M	63.76M	59.83M	47.54M	42.34M	40.43M	38.77M	38.29M	37.58M	25.06M	14.21M	3.66M	106.68K	-	-	95.91M
EPS (Basic)	-1.5	-4.37	-3.01	-3.56	-3.46	-2.54	-1.54	-1.29	3.49	-4.43	-2.38	-8.29	-0.14	-	-	-0.00
EPS (Diluted)	-1.5	-4.37	-3.01	-3.56	-3.46	-2.54	-1.54	-1.25	3.17	-4.43	-2.38	-8.29	-0.14	-	-	-0.00
EBITDA	-326.25M	-299.42M	-186.68M	-143.95M	-107.21M	-73.39M	-38.67M	-38.79M	129.46M	-74.11M	-34.29M	-30.11M	-12.82K	-	-	-18.27K
Depreciation & Amortization	38.53M	20.72M	26.62M	25.79M	20.41M	18.67M	17.80M	16.14M	13.39M	5.40M	215.99K	124.89K	-	-	-	-